ArticleEuropean clinical respiratory journal2025

Serologically assessed markers of fibroblast activity (PRO-C3 and PRO-C6) and risk assessment of pulmonary fibrosis following severe COVID-19 infection.

Anne Orholm Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.